Monday, December 28, 2009

Sweden stops the vaccine

We ordered 19 million doses - but only need half. Now the authorities have managed to stop the deliveries temporarily.
Vaccine deliveries to Sweden are stopped.


The delivery of the vaccine against swine flu are to be stopped from early January. That is the outcome of an agreement between several Swedish authorities and the vaccine manufacturer Glaxo Smith Kline, says Sveriges Radio Ekot.
Sweden was one of the few countries that made a deal with Glaxo Smith Kline for complete coverage and ordered 18 million doses of vaccine. When the recommendations were changed later from two to one dose per adult, it was clear that Sweden would have a large surplus of the vaccine.
But now, Swedish authorities have managed to stop further deliveries temporarily. In January,by which time 10 million doses will have been delivered, no further deliveries will be made.

Original article
Furthermore, the article states that the vaccination campaign will not stop and everyone that would like to get the vaccine should be able to. It also states that 60% of the Swedish people have received the shot and that another 20% would like to. These numbers need to be confirmed by going through all data after the holidays to know exactly how many in Sweden actually received the poisonous Pandemrix "swine flu" vaccine.

The wording of the article is interesting since the politicians are presented as if they are proud they managed to stop the deliveries. This gives the impression that the pharmaceutical companies are much more powerful than individual governments and countries. If this is true, it certainly explains a few things about the massive pandemic scare and vaccination campaign.

The temporary stop will be reevaluated in February.
Since Swedish citizens have a tendency to trust their government and authorities, especially "science", very many actually believed they would be better off having the vaccination and therefore large numbers in Sweden got the shot. This will result in very large amount of damages, something the Swedish authorities and media openly reported for about one week until it became clear the coverage of the damage was stopping the massive vaccination campaign.
After that, very few reports have appeared about damages from the vaccine. Judging from the initial data, more than 150 people can be assumed to have died from the poisonous Pandemrix "swine flu" shot and several hundred abortions can be assumed to have been triggered by the same vaccine. It is uncertain if the damages will ever be properly investigated and even if they were, if they ever will be made public.
Other severe cases of damages, judged from the initial reports, should be in the number of thousands. The standard tactic to deal with these are either to declare them as "expected and normal" and in that way ignore them or to claim they had nothing to do with the vaccination.

That Sweden have "managed" to get out of the contract with GSK should inspire other countries to do the same with their respective vaccine suppliers.

Sweden have been hit by the largest medical scandal in modern times and for many years this massive mass vaccination will result in hundreds of thousands of severely damaged and sick individuals, suffering from a wide variety of symptoms as seen in the Gulf War Syndrome cases.

Johan Niklasson

BIOLOGICAL ATTACK PLANNED IN US IN JANUARY?

According to a man claiming to be a US army colonel, massive amounts of mutated swine flu and bird flu H1N5 viruses are being transported in refrigerated trucks to Texas and New Mexico for storage in military installations with air craft facilities ready for being released in January.

http://video.aol.co.uk/video-detail/h1n5-mutated-virus-to-be-released-early-january/2508251138

DANISH BOARD OF PHARMACEUTICALS MUZZLES A MEDICAL DOCTOR

By Louise Voller, Kristian Villesen

December 20, 2009

AFTER CRITICAL COMMENTS ABOUT THE DANISH GOVERNMENT’S PURCHASE OF TAMIFLU, A MEDICIAL DOCTOR FROM THE GOVERNMENT INSTITUTE FOR RATIONEL PHARMACOTHERAPHIA (IRF) HAS BEEN MUZZLED.

THE EXPLANATION IS THAT PURCHASES FOR FLU EMERGENCIES LIES BEYOND THE COMPETENCES OF THAT INSTITUTION, EXPLAINS THE DIRECTOR OF THE DANISH BOARD OF PHARMACEUTICALS

After critical remarks about the Danish government’s purchase of the flu remedy, Tamiflu, medical doctors from the Institute for Rationel Pharmacotheraphia are no longer allowed to talk to the press on this subject.

The order was issued by the director of Danish Board of Pharmaceuticals (Laegemiddelstyrelsen), Jytte Lyngvig.

In a news item in the Danish daily newspaper, Information, on December 8, several experts, among them Niels Heebøll-Nielsen, from the Institute for Rationel Pharmacotherapia critisized the Danish government’s purchase of significant quantities of Tamiflu.

Simultanously the daily Information and British Medical Journal published a new and extensive evaluation of scientific data concerning Tamiflu. The study made it clear, that Tamiflu has “a very limited effect” on the sickness accompanying swine flu and at best, might “suppress the symptoms one day”.

In Denmark one million doses has been purchased at a cost of 65 million Danish crowns.

REASONABLE

The Institute for Rationel Pharmacotheraphia gives advice concerning appropriate use of medicine, which would, so one might think, qualify medical doctor Niels Heebøll-Nielsen to give an opinion as to whether the state has acted irrationally and purchased too much.

To Information, he said among other things that the purchase was characterized by the atmosphere of panic prevailing after the outbreak of SARS:

“When fear arises and an atmosphere of doom and disaster is spreading then at the same time an expectation occurs that something will be done. It is understandable. And they must have believed in Tamiflu having an effect”.

Furthermore he criticised the foundation for the purchase:

“When you buy great quantities of medicine, it would be convenient if you knew more about what you get for the money. That knowledge it seems has been insufficient concerning Tamiflu. But they must have trusted that it was efficient. There were no alternatives,” he says.

RATIONEL

The Institute for Rationel Pharmacotherapia belongs to the Board of Pharmaceuticals, and in Board of Pharmaceuticals they don’t hold opinions at all concerning the handling of the emergency, explains the director of that institution, Jette Lyngvig.

“The Board of Pharmaceuticals has absolutely nothing to do with this. It is Danish Board of Health who is the purchaser” says Jytte Lyngvig.

Accordingly, Niels Heebøl-Nielsen as an employee of Institute for Rationel Pharmacotheraphia is not allowed to express opinions concerning the pandemic emergency.

“He may say whatever he wants as a private person. But this one is the decision of Danish Board of Health. Therefore it is only reasonable, that it is up to them to comment on this matter.”

It would be reassuring to know there are experts who are able to give a critical evalunation?

“Then you will have to speak to medical doctors at the hospitals”.

„Is Institute for Rationel Pharmacotheraphia generally allowed to be critical about the way we use medicines?

“Yes but only the daily use of medicine. Not in relation to a pandemic. The institute has no role to play in a pandemic. When he speaks on behalf of the institute, it has to fall inside the limits of the activities of this institute. When one profits by the name, people could get confused because the Institute for Rationel Pharmacotherapia holds an opinion about this matter.”

But he usually evaluates what is a proper use of medicine?

“No, for he has never been part of the purchasing for an emergency. If he criticises the efforts of Danish Board of Health, he must do so as a private person”.

Do you think he would like to do that in the future?

“I don’t know. But I could well image that he would”.

Tuesday, December 22, 2009

Inside the Labyrinth- CFS/ME and the research- or lack thereof

OSLERSWEB.COM Hillary Johnson December 5, 2009

When did it stop being about you and become all about them?
Was it when they decided to pull their funding from a scientist who found evidence for a retrovirus, once she was thoroughly ground up in the cannibalistic maw of the Centers for Disease Control in 1991?
Marc Iverson, the North Carolina scion of the Nucor Corporation who founded the CFIDS Association--purportedly a patient advocacy organization--said he decided to pull the plug because Elaine DeFreitas had been so tarnished by CDC that even if she ultimately nailed down the causative virus, no one would believe her after the government mauling.


In 1995, David Bell told me, "Three years ago I came to understand that the CFIDS Association offered [DeFreitas] up. They said, 'We need to be on the good side of the CDC and the NIH.' Basically, there was a certain point at which the politics came up and the money thing came up, and they decided it was time to dump her," Bell added. "I'm stunned that somebody could be hurt so much."
Maybe that's when it stopped being about you. Eighteen years ago. When it was clear that instead of fighting for patients, or scientists who were trying to help patients, their ultimate goal was to get cozy with the CDC and the NIH.


When did it stop being about you and start becoming all about them?
Was it in 1994, when editors of the CIFDS Association's newsletter, its primary communication conduit with its members, were increasingly prone to submitting articles containing even mild criticism of federal researchers and policymakers directly to those researchers and policy makers for review prior to publication? Late that year a former college instructor, sick for thirteen years, proposed an article about the "paltry response" of the government to the epidemic. She reported that she was told that her article "might have to be cut, because the CFIDS Association (was) trying to work with the government."


Was that when it stopped being about you and started becoming about them?
To a disgruntled member of the group's Public Policy Advisory Committee, executive director Kim (Kenney) McCleary wrote that same year, "[You] want the Association to discontinue its present style of advocacy and employ 'rage' tactics similar to those employed by Act-Up and aggressive activist movements in the breast cancer movement...While I agree that we have a great deal to learn from the successes achieved by AIDS and breast cancer activists, there are several barriers to the Association adopting an advocacy style that depends so heavily on these strategies. First CFIDS is not accepted by the general public as a serious, threatening illness, like AIDS and breast cancer are. Second, there are no well-funded public education campaigns to provide a foundation for enlisting the general public in our efforts at this time. Third, rage, while powerful, is a volatile emotion that requires and consumes tremendous amounts of energy (and political capital) to sustain. It is difficult to control and can easily backfire. It erupts spontaneously in response to an incident or crisis and then peaks and subsides quickly. We must use it judiciously."
Kenney advised that in the years to come, "the Association will continue to build on [a] moderate, essentially mainstream, approach to advocacy."

At the time, Paul Cheney found a certain irony in the group's newfound compliance with NIH and CDC administrators. "It's an aspect of institutional growth," he told me. "They now see themselves as part of the establishment, and they're adopting the methods of the establishment."
Maybe that's when it stopped being about you, in 1994--fifteen years ago--and started being about them.
Was it the day Osler's Web, the first and only major book, nine years in the writing, about the government's negligent history in your disease, was published in April of 1996? That day, shortly after I appeared on Good Morning America, an unidentified person called my publisher's publicist, reached an inexperienced secretary, told her a tall tale about who they actually were and persuaded the secretary to fax them a copy of my nine-day, seven city book tour schedule, which outlined in detail every radio interview, every television appearance, every newspaper interview and every bookstore appearance I would be making.
For the next nine days, I was haunted in interview after interview by the specter of retired NIH scientist Paul Levine, who in apparent obesience to the CFIDS Association, interfered with my ability to discuss with my interviewers the news and information that was actually in the book. Levine just happened to phone into every radio show in every city I was booked on, throwing around his weight as a former government scientist to get on the air and engaging me in one hysterical debate after another about whether "CFS" was infectious. In the press biz, that's what you call a "Truth Squad."


When I covered Jane Fonda and Tom Hayden for Life magazine in the late 1970s while they campaigned, they were met everywhere by truth squads, too; nerdy-looking guys holding up signs that read, "Nuclear Energy Never Hurt Anyone." But why would a patient advocacy organization sick a Truth Squad on an author who was trying to publicize an important book on the complex and highly politicized nature of the federal research on that disease? A book that offered the first hard evidence of fiscal malfeasance and scientific fraud at the Centers for Disease Control?


Was that when it stopped being about you--patients--and started being about them? Fourteen years ago?
Or was it when the CIFDS Association trashed the book in their newsletter, causing my incredulous publisher to ask, "But why would a patient organization do that?"
Was it when the CFIDS Association called up the organization known today as the IACFS to ask its members to issue a press release attacking the credibility of Osler's Web? Dutifully, the members of this organization engaged in a round of hasty faxes (I have their correspondence), to arrive at their condemnation of Osler's Web and its author. Exactly one member dissented and refused to sign on to the press release: Dan Peterson, who remarked that instead of attacking Osler's Web, members should celebrate the occasion of the book's publication as the first real opportunity to engage the public in a conversation about the serious nature of this disease and the changes that needed to be made inside the federal health agencies. Peterson's proposal was overruled.


A press release was distributed. It's gist: journalists didn't have the right to write about science; only scientists had the right to write about science. Interesting--since virtually every member of this organization had agreed to countless lengthy interviews with me over the years and were fully aware that I was a journalist, not a scientist. I guess these folks think journalists should write about science as long as they function as stenographers. (The press release remained on this organization's website for the next eleven years, until the site underwent a redesign in time for the organization to request donations from patients, at which point they removed it.) Fortunately, no one in the media paid any attention to this document; Osler's Web received wonderful reviews from professional book reviewers, but what does this episode say about the ethics and motives of the CFIDS Association? What about my book scared them so much? Did it expose, unintentionally, their failure to advocate for patients?


Early on in my reporting for Osler's Web, long before the CAA was a national organization, it's founder Marc Iverson paid my airfare and hotel expenses so that I could attend three medical conferences related to "CFS." In return, I wrote three stories for the fledgling newsletter describing those conferences in some detail, helping their members stay abreast of scientific developments. It seemed a reasonable exchange: I had no money, they needed a writer. Had I been working for a magazine, I would have been paid for my writing, too, but I was repsectful of their non-profit status, and they left my reporting alone. Years later, when my book came out, I thanked them along with the Fund for Investigative Journalism, which gave me a grant (and asked for nothing in return) in the frontspiece of my book. Apparently--perhaps because the book was not all about them--their impulse was to manufacture an ad hominem assault in tandem with the rest of their frantic activities described above. It's demonstrative of one of the organization's major failings: They have no real concept of a free press, or of what journalists actually do; they apparently fail to distinguish between journalism and public relations.


Did it stop being about you in 1998, when Kim Kenney and her lobbyist Tom Sheridan took Bill Reeves under their wing and helped him obtain Federal Whistleblower status? Even though, two years earlier, Osler's Web had provided abundant evidence that Reeves and his agency were the PROBLEM? It wasn't even necessary to have read the book. By 1998, anyone with the most minimal understanding of what was going on was aware that the Centers for Disease Control were dissembling, stalling and hurting patients, depriving them of their civil rights and impeding their access to medical care. Kim and Tom made sure Bill Reeves would be in charge of your disease for years and years to come; they cemented him down, providing him immunity even from being fired by his own superiors.


Was that when it stopped being about you and started being all about them? Eleven years ago?
Did it stop being about you, and start being all about them, when, having revealed themselves to be supporters of the very agency that had hurt patients so profoundly, they signed on as a government contractor to the Centers for Disease Control in return for $4.5 million? And what did they agree to do for the CDC in return for that money? "Brand" the agency's false construct "chronic fatigue syndrome" into the mainstream through websites, TV ads, and a collection of photographs by an expensive fashion photographer, which is still traveling the malls of America. And that's been helpful, hasn't it?
In 2006, they spent about $3.5 million on public relations for CDC, and less than $200,000 on lobbying for your disease in Congress. How did your life improve as a result of the CAA's multi-million contract with CDC? Did the NIH start funding research? Did the CDC start doing epidemiology? Did anyone in Congress stand up and demand an investigation into the shady activities going down in Atlanta? Were you, or your loved ones, aided in ANY palpable way at all?


Is a patient advocacy organization still a patient advocacy organization when it becomes a contractor to the very federal agency responsible for the desperate plight of patients?
How about NIAID director Anthony Fauci's 2001 decision to stuff your disease into the Office of Research on Women's Health, a virtual janitor's closet at the NIH, where, along with the brooms and mops, your disease was effectively disappeared when the door slammed shut? Exactly where was the CAA when this went down? Hobknobbing with the executives in this office, forging ever more cozy ties while the ORWH made sure the NIH continued its policy of failing to pay for research into your disease. Why wasn't there instead a demand by CAA for a Congressional investigation into the NIH's handling of a devastating, likely infectious disease of, by then, one million people?


Is that when it became all about them, and not about you? Eight years ago?
Did it become all about them, and not about you, in 2006, when Kim McCleary, her organization under contract with CDC, played hostess and enabler to the CDC's roll out of its theory of causation at the National Press Club in Washington, D.C.? Suzanne Vernon and her boss Bill Reeves presented their eugenicist explanation of the disease and the stenographer-reporters ate it up: genetic predisposition to being unable to handle stress + childhood abuse = CFS. Oh, and by the way, as many as ten million people had this "illness," and most of them had yet to be diagnosed, they added. Remember: “Get Informed, Get Diagnosed, Get Help”? The headlines went viral. Twenty-one years after Tahoe, and after hundreds of millions of dollars wasted by CDC on Abt Associates and the CFIDS Association, and the message was the same: chronic fatigue syndrome was not a medical disease, it was a lot of stressed-out, traumatized people. CAA faciliated, enabled, this gargantuan lie, yet again selling out patients. And why? For money and for the self-aggrandizing appearance of power?
Is that when it started to be about them, and not about you?


A few months later, I encountered Suzanne Vernon at a medical conference and asked her about that lie, the one about the number of people with CFS and CDC/CAA's emphatic insistence that eighty percent of them weren't diagnosed. After fifteen minutes of heated discussion, Vernon finally admitted none of it was true; she admitted to the lie. "But Hillary," she said, as if she actually knew me, "aren't you happy that CDC is finally doing something about this disease?" And I was left speechless. This person calls herself a scientist? She admits CDC is lying to the press, to patients, but wonders why anyone would fail to be less than happy about it? Haven't there been enough lies? I am, we are, supposed to be "happy" that this CDC/CAA hybrid Medea is spending millions of dollars to market yet another lie?
And where does happiness enter into this equation? Is anyone seeking happiness from CDC? I don't know about you, I used to seek science from CDC. On top of the lies, it's that kind of condescension, that smarmy "poor you" mentality that pervades the leadership the CFIDS Association, that's so nauseating, that has that fingernails-on-the-chalkboard quality. In person, and in their literature, they inevitably sound like they're addressing the newly-lobotomized.

Did it become all about them, and not about you, when the CDC's Suzanne Vernon moved over to the CAA shop? Vernon, who told someone I trust that during the decade she worked alongside Bill Reeves manufacturing abnormal science that the remarks, the activities, the jokes, the attitudes about you and your disease among her colleagues was so appalling that she could not discuss that history in any detail, she was just so ashamed to have been part of it? With Suzanne Vernon's leap from Atlanta to Charlotte, CDC DNA was fully co-mingled with CFIDS DNA. One could employ the Trojan horse analogy about Vernon, but I think its worse than that. It’s not that one of the top “scientists” in the fraudulent CFS program at CDC has surreptitiously invaded a patient organization. Matters have progressed much farther than that. The CDC and CAA actually became one, as in “co-mingled,” ages ago. At this point, it's an inextricable mess. Anyone see Jeff Golblum in the 1989 remake of "The Fly"? You know--what's Brundle (the mad scientist), what's fly? In the end, Brundle was pretty much all fly.


Did it become all about them, and not about you, when the CFIDS Association sought to position itself as a kind of mini-research institute, a provider of grants to scientists, with former CDC scientist Suzanne Vernon the arbiter of what was and was not worthy science? Was it about them, or about you, when Vernon and McCleary turned down no fewer than six grant proposals from the Whittemore Peterson Institute?
This litany is hardly complete--in fact, it's woefully inadequate, because I've left out all the backroom wheeling and dealing on Kim McCleary's part, the years and years of brokering partnerships, kissing up to and making friends with, enabling and facilitating, the very people in government whose activities prevented you from getting appropriate medical help, which has been the true legacy of the CFIDS Association. McCleary’s brand of “moderate, essentially mainstream” advocacy has amounted not to advocacy but instead to McClearly’s having a voice at major CDC conclaves on this disease, like the agency’s “Blue Ribbon” committee a few years ago to evaluate the CFS program in the agency.
She has failed to use her access, her voice, in any way that might have been helpful; instead, she has identified with government officials and their problems instead of your problems; she’s made it easy for them to keep you quiet and (and sick), all the while assuring you in that unctuous, phony PR patter that she’s on top of things.

But, I'll just jump to the critical present moment. Since October 8, 2009, the CFIDS Association appears to have been awash in a truly absurd jealousy over the WPI discovery of XMRV in "CFS." And isn't that more about them than about you?
Instead of hailing the finding of XMRV as the long-overdue solution to this disease, Vernon and McCleary mimicked the Centers for Disease Control, an entity with more reason than any to cast this unimpeachable finding into the Waring blender of obfuscation, but then, as I've suggested, the CFIDS Assocation is CDC, and vice versa. Vernon and the CFIDS Association fell all over themselves in an effort to caution that XMRV will probably apply only to a "sub-set;" it may be a "passenger;" the patients weren't well characterized; there must be co-factors, in other words, it's multi-factorial. A patient advocacy organization that knew what it was doing would jump all over XMRV, using this discovery to advocate for patients at the highest levels of government; why, instead, did the CFIDS Association just echo the CDC?
Their sister agency CDC, would like you to believe the same about XMRV: multi-ignorance. I suspect thats what Anthony Fauci at NIAID hopes you believe, too; it gives NIAID a reason to do NOTHING. (Watch NIAID carefully; by the way. Will Dr. Fauci, NIAID's Napoleonic chief, take on this major infectious disease, or will he continue to insist it's mental illness?) Without appropriate political pressure from patient advocates, National Cancer Institute scientists--who are the best you've got--may find a reason to move off XMRV and CFS, too, and move instead onto XMRV and other diseases it might cause, especially and, in fact probably exclusively, cancer.


The CFIDS Association wants you to get behind THEM, as usual, not XMRV. They didn't discover XMRV--and how could they? They're not scientists. XMRV did nothing to advance their hegemony, which made it virtually useless to them. (Until they figure out a way to harness the discovery to lend them prestige or the appearance of authority.) Besides, XMRV is an infectious, cancer-causing retrovirus, and we know how they hate infectious diseases.
Mikovits et. al. have moved this disease out of the muck and into the world of white glove science. Will the CFIDS Association be able to get away with its pretense of patient advocacy much longer? Or will it finally be recognized as a government public relations agency paid to keep the status quo? A lot depends on you.
HIV was hailed as the cause of AIDS in the U.S. in the spring of 1984, after the NCI found isolates in fewer than fifty patients. A few weeks later, an NCI scientist isolated the virus from the blood of a nurse in Los Angeles who fell ill with AIDS after a blood transfusion and the virus was found in the donor blood. That's all it took. Less than a year later, on March 2, an FDA-approved commercial antibody test from Abbott Labs became available to search for the virus among blood donors. Meanwhile, AIDS advocates demanded that drug development begin immediately, and so it did.


Kim McClearly appears to have learned nothing about the tactics used by AIDS activists, or breast cancer activists, though she admitted in 1994, fifteen years ago, she had much to learn. I suggest she is completely uninterested in those tactics; she is instead interested in nurturing her good relationships with administrators at federal agencies who have done nothing to help, and everything to hurt, patients. Nancy Klimas' AIDS patients are "hale and hearty," in Klimas' words; her CFS patients have been sick as dogs for years and years. Imagine a parallel universe where AIDS patients in 1984 gave up their collective power and agreed to be represented in Washington, D.C. by a "patient advocacy" group with the flawed agendas of the CFIDS Association! Where would they be now? Where we are now?


If the CFIDS Association was the patient advocacy group you deserved, it would not be playing politics with you or with XMRV, it would be taking this finding and running with it instead of suggesting it's a passenger, a co-factor, a sub-set or part of some multifactorial multi-ignorance. With one hand it would be demanding to know why it took 26 years, and a private philanthropic effort, to find XMRV. With the other hand, it would be demanding clinical trials and drug development at FDA, instead of warning you it might take years for therapies to be developed. (If you accept that lying down, it’s virtually guaranteed it will take years.) It would be asking why CDC is wasting time trying to replicate the finding in CDC-selected patients instead of turning the agency's full capabilities toward determining the presence of XMRV in the population. It would be calling for Anthony Fauci's resignation from NIAID.


Over the last quarter century, the question has arisen again and again: why are “CFS” patients so "passive"? Why have they allowed this organization to speak on their behalf and negotiate their relationship with federal health agencies for them? Arguments advanced have included, they’re too sick, which, to me, has always had legitimacy, and, “They’ve got Stockholm Syndrome,” which to me does not have legitimacy, maybe because my life experience has made me leery of nearly every psychologically-based theory of behavior. I think people with this disease have had enough contemptuous armchair psychology thrown at them. I do wonder if people are intimidated, however; if people who have already been so marginalized and abandoned might be more than unusually sensitive to fears of reprisal and dismissal. To have this disease, almost by definition, is to feel disenfranchised, alone, discarded. Does that make it infinitely harder to rock the boat?
Even the CFIDS Association appears to realize it finally may have gone too far this time. Yet, the best the CFIDS Asociation has been able to come up with is a muted apology for its lack of enthusiasm for the fact that an oncogenic retrovirus—hints of which have been present for the last twenty-five years—has been isolated in patients. Tellingly, the apology seems to be more about failing to adopt the right "tone" and craft the "message" properly than about anything else:


"Content, tone and timing are all important and, at times, we acknowledge that we have gotten only one of the three completely right. And we recognize that these missteps have created some questions and strong feelings about our response to the XMRV study. Be assured that we share the hope and anticipation that these important findings will lead to immediate advances in diagnosis and treatment. And know that we're listening to feedback, shared both directly and indirectly, with us. We're constantly working to refine our messages to ensure that we deliver the factual, focused communications you count on."
To which I would say, Stop refining already! Seeking to craft and manipulate reality is just another way to mislead, not far removed from lying.


Where is the ADVOCACY? Where are the DEMANDS? What is the STRATEGY?
The discovery of XMRV's powerful association with "CFS" is a defining moment; it's the paradigm change that was so desperately needed. I've heard a number of scientists say, "We're where we were when HIV was discovered." I think in terms of patient advocacy, one could say the same. But Kim McCleary's CIFDS Association isn't up to the job; it sold out years and years ago. The organization has a bright future as a public relations firm for corporate entities wishing to curry favor with CDC and NIH. It's beautifully-positioned to do that. Two decades after it began making deals with the devil, is it too soon to say good luck and good bye to the CAA?
Like CDC, the CAA is unlikely to go away, of course. As individuals, they're deeply entrenched and invested, as is their brand. They make their counterparts in government feel comfortable. But we need some uncomfortable voices now.


I suggest that it is time to start asking what actions need to be taken to advance XMRV down the court. It’s time for new organizations to be forming. Time for the advocates who are ready to make the right demands of the right people to stand up and let the CDC and NIH know that the CFIDS Association of America isn't the only game in town. It’s time for advocacy organizations that focus on political strategy exclusively instead of attempting to conduct research, the government's job; time for an organization that refuses to become party to the government for millions of dollars in remuneration, selling out patients in the process. Time for an organization with an effective media strategy, one that includes pushing stories about the government's history of scientific fraud and corruption in the realm of this disease instead of weepy human interest stories that promote poster children instead of scientific understanding.
If none of what I've written here rings true, then I am obviously alone in this matter. Certainly, I've been on the receiving end of the CAA's wrath, which gives me some added oomph, but my point here is that every one with this disease has been on the receiving end of the CAA's passive aggressive representation, everyone has been sold out, again and again. And so I continue to suggest it's time to at least consider that it's all about them, and not about you.

###

Addendum: I wrote this two weeks ago, and then decided not to publish it. Why bring people down at what is certainly the most promising moment in the history of this disease? But I recently looked at the CAA website and read the latest comments by Suzanne Vernon. Hewing to the CAA’s imperative of self-promotion and self-congratulation in every word and deed, Vernon actually touts the fact the CAA provided seed money to Elaine De Freitas, apparently in an effort to demonstrate that the CAA was first on the block in the retrovirus hunt and actually moved the science forward.
Vernon keeps the CAA ethos alive. Ever eager to whitewash history, the imperative being to promote the CAA regardless of the truth, she and her organization seek to twist the reality of what it did in 1992, presumably in case anyone reads the real history and realizes the extent of the CAA’s duplicity. In the CAA cosmos, spin is everything.
Vernon fails to mention that in fact CAA withdrew its support of DeFreitas at the most crucial moment imaginable, a move that allowed the scientist’s findings, and her reputation, to crash and burn. CAA “enabled” CDC to further disappear your disease. CAA’s withdrawal of support meant that for the next twenty years, the search for the viral cause of this disease languished while psychiatrists defined the disease and the cause—a process in which Vernon was intimately involved by virtue of her work with Bill Reeves at CDC. And that’s just another way the CAA has hurt you over the years.
If you add up McCleary's and lobbyist Tom Sheridan’s salaries over the last twenty years—say $100,000 each per annum, a generous underestimate—you get $4 million. That’s how these two profited off this disease, at a time when a million very sick people lost their incomes.
What more can one say about this slick, overblown operation? It exists to keep McClearly, Sheridan and now Vernon, comfortably employed. What else it does that is actually helpful to you, I cannot say.

Dr. Julie Gerberding Named President of Merck Vaccines

This is the most disgusting and BLATANT example of the revolving door between the CDC, the government and vaccines. We really must revolt. Today, Merck announced that Dr. Julie Gerberding has been named president of Merck Vaccines, effective January 25, 2010. Dr. Gerberding was the director of the CDC from 2002 to 2009.

 

Merck NEWSROOM

Dr. Julie Gerberding Named President of Merck Vaccines

Dr. Julie GerberdingWHITEHOUSE STATION, N.J. – Dec. 21, 2009 – Merck & Co., Inc. (NYSE: MRK) today announced that Dr. Julie Gerberding has been named president of Merck Vaccines, effective January 25, 2010.

Dr. Gerberding led the Centers for Disease Control and Prevention (CDC) as director from 2002 to 2009. During her tenure at CDC, Dr. Gerberding led the agency during more than 40 emergency response initiatives for health crises including anthrax bioterrorism, food-borne disease outbreaks, and natural disasters, and advised governments around the world on urgent public health issues such as SARS, AIDS, and obesity.

“Vaccines are a cornerstone of Merck's commitment to health and wellness," said Richard T. Clark, chairman and chief executive officer, Merck & Co., Inc. "We are delighted to welcome an expert of Dr. Gerberding's caliber to Merck. As a preeminent authority in public health, infectious diseases and vaccines, Dr. Gerberding is the ideal choice to lead Merck's engagement with organizations around the world that share our commitment to the use of vaccines to prevent disease and save lives."

"I’ve had the privilege in my previous work in academia and in the federal government to be a passionate advocate for public health priorities such as vaccines, which are an imperative component of global health development," said Dr. Gerberding. "I am very excited to be joining Merck where I can help to expand access to vaccines around the world."

Dr. Gerberding will lead the company's $5 billion global vaccine business. Merck currently markets a broad range of pediatric, adolescent and adult vaccines and is a leading provider of vaccines in countries around the world; in the U.S., Merck markets vaccines for 12 of the 17 diseases for which the U.S. Advisory Committee for Immunization Practices currently recommends vaccines. She will be responsible for the commercialization of the current portfolio of vaccines, planning for the introduction of vaccines from the company's robust vaccine pipeline, and accelerating Merck's on-going efforts to broaden access to its vaccines in the developing world. Dr. Gerberding will also collaborate with leaders of Merck Manufacturing Division and Merck Research Laboratories to manage the critical linkages between basic research, late-stage development and manufacturing to expand Merck's vaccine offerings throughout the world.

She received her undergraduate degree and her M.D. from Case Western Reserve University. Her internship, residency, and clinical pharmacology training were all at the University of California, San Francisco (UCSF), where she worked in a range of clinical, research and teaching roles prior to joining the CDC in 1998. Dr. Gerberding received her Masters of Public Health at the University of California, Berkeley.

She is a member of the Institute of Medicine and a fellow of the Infectious Diseases Society of America and the American College of Physicians, and is board certified in Internal Medicine and Infectious Diseases. She is also a Clinical Professor of Infectious Diseases at Emory University and an Adjunct Associate Professor of Medicine in Infectious Diseases at UCSF.

Dr. Gerberding has received more than 50 awards and honors, including the United States Department of Health and Human Services (DHHS) Distinguished Service Award for her leadership in responses to anthrax bioterrorism and the September 11, 2001 attacks. She was named to Forbes Magazine's 100 Most Powerful Women in the world in 2005, 2006, 2007, and 2008 and was named to TIME Magazine's 100 Most Influential People in the World in 2004.

About Merck
Today's Merck is working to help the world be well. Through our medicines, vaccines, biologic therapies, and consumer and animal products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching programs that donate and deliver our products to the people who need them. Merck. Be Well. For more information, visitwww.merck.com.

Forward Looking Statement
This news release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such statements may include, but are not limited to, statements about the benefits of the merger between Merck and Schering-Plough, including future financial and operating results, the combined company’s plans, objectives, expectations and intentions and other statements that are not historical facts. Such statements are based upon the current beliefs and expectations of Merck’s management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements.

The following factors, among others, could cause actual results to differ from those set forth in the forward-looking statements: the possibility that the expected synergies from the merger of Merck and Schering-Plough will not be realized, or will not be realized within the expected time period, due to, among other things, the impact of pharmaceutical industry regulation and pending legislation that could affect the pharmaceutical industry; the risk that the businesses will not be integrated successfully; disruption from the merger making it more difficult to maintain business and operational relationships; Merck’s ability to accurately predict future market conditions; dependence on the effectiveness of Merck’s patents and other protections for innovative products; the risk of new and changing regulation and health policies in the U.S. and internationally and the exposure to litigation and/or regulatory actions.

Merck undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in Merck’s 2008 Annual Report on Form 10-K, Schering-Plough’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2009, the proxy statement filed by Merck on June 25, 2009 and each company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site: www.sec.gov.

Monday, December 21, 2009

Is WHO covering up a tuberculosis epidemic with fake H1N1 panic?

By F. William Engdahl, 18 November 2009

What is clear around the world to date is the fact that despite declarations of public health emergency in the United States, Ukraine and despite the groundless WHO designation of an alleged H1N1 Influenza A “pandemic” situation, despite reckless government decisions to allow “fast track” production of vaccines for an H1N1 virus whose existence nowhere to date has been scientifically and verifiably proven to exist, the feared H1N1 is proving to be little more than the typical seasonal flu wave that inevitably comes with cold weather.

Yet there are reports, notably most recently in Ukraine, of deaths of people attributed to H1N1. Increasing evidence suggests that what is causing deaths is not at all some Swine Flu of pandemic proportions.

Evidence suggests people are dying from tuberculosis. According to Wikipedia on tuberculosis, “Most infections in humans result in asymptomatic, latent infection, and about one in ten latent infections eventually progresses to active disease, which, if left untreated, kills more than half of its victims. The classic symptoms are a chronic cough with blood-tinged sputum, fever, night sweats, and weight loss.”

TB is a disease that is associated with poor living conditions, malnutrition and poverty.  In 2007 there were an  estimated 13.7 million chronic active cases, 9.3 million new cases, and 1.8 million deaths, mostly in developing countries. About 80% of the population in Asian and African countries test positive in tuberculin tests, while only 5-10% of the US population test positive.1

The WHO states about TB, “Tuberculosis (TB) is a contagious disease…Now, strains that are resistant to a single drug have been documented in every country surveyed; what is more, strains of TB resistant to all major anti-TB drugs have emerged. The World Health Organization (WHO) estimates that the largest number of new TB cases in 2005 occurred in the South-East Asia Region, which accounted for 34% of incident cases globally. However, the estimated incidence rate in sub-Saharan Africa is nearly twice that of the South-East Asia Region, at nearly 350 cases per 100 000 population.”

The highest mortality from TB per capita according to WHO are in the Africa Region. Africa also happens to have some of the world’s most impoverished populations ravaged from wars, drought, IMF conditionalities, economic privations, lack of water sanitation.

Notably, in recent years since the 2004 Orange Revolution, the economic living conditions in Ukraine have approached that of a Third World country in many parts of the country.

Viral Pneumonia or TB?

Four men and one woman have died from the flu in Lviv, said emergency hospital chief doctor Myron Borysevych. Two of the dead patients were in the 22-35 age group, with two others over 60. He diagnosed the disease as viral pneumonia. “We have sent the analyses to Kiev. We don’t believe it’s H1N1 swine flu. Neither do we know what kind of pneumonia it is.” A doctor in Western Ukraine who did not want to be named, told a British paper, “We have carried out post mortems on two victims and found their lungs are as black as charcoal. They look like they have been burned. It’s terrifying.”2

Curiously, after days of receiving samples from patients believed to have H11N1 in Ukraine, the WHO Reference Lab in the UK has yet to make a statement confirming or denying H1N1 presence.

One alternative explanation for the deaths and the ghastly lung conditions of the dead in Ukraine comes from an American medical researcher, Dr. Lawrence Broxmeyer, MD, of the New York Institute of Medical Research. Broxmeyer is convinced that the H1N1 Influenza A is no flu at all.

The current Swine “flu” pandemic began in La Gloria, a pig-farming village in the Veracruz mountains of Mexico. As Broxmeyer points out, “Surely, if any place could unlock the true nature of the cause of the 2009 Pandemic, it would be found in La Gloria, whose villagers were certain that they were sickened by the surrounding pig farms, which they accused of polluting their air and water with pig waste. This is much like what happened in Haskell County, Kansas in 1918, original site of the Great Influenza Pandemic of 1918.”

He notes revealingly that Enrique Sanchez, top official from Mexico’s Agriculture Department, could not find H1N1 in mucous samples taken from the pigs several weeks later, on April 30th. Common bacteria were also tested for.

“However, Broxmeyer states, “no studies were done to rule out Swine tuberculosis which is predominantly avian and to a lesser extent bovine, and could have also accounted for the wholesale “respiratory” problems the villagers were experiencing.”

Soon, more than half of La Gloria’s 3,000 residents fell ill with FLU-LIKE illness, type unknown. More than four hundred of the sickest of these where treated with antibiotics and masks. The diagnosis? “Acute respiratory infections.” By the time the mucous test results came through in early April, most of the villagers had recovered, the more serious cases on antibiotics alone. The “virus” seemed to have left their systems. As Dr. Broxmeyer notes, “since antibiotics don’t cure ‘viruses’ what infectious disease in these purported “Influenza” victims had been cured by the antibiotics given?”

Broxmeyer cites my article of June 2009 which appeared inKopp Exclusive entitled “Sarkozy’s Secret Plan for Mandatory Swine Flu Vaccination.” He notes, “Engdahl plainly stated there that, “The only problem with the Swine Flu (H1N1) Vaccine, is that to date, neither WHO nor the US Government’s Center for Diseases Control (CDC) have succeeded to isolate, photograph with an electron microscope, or chemically classify the H1N1 Influenza A virus.” Furthermore there was no scientifically published evidence that French virologists have done so either. Therefore, mentioned Engdahl, “To mandate a vaccination for a putative (supposed or assumed to exist) disease that has never been characterized, is dubious to say the least.”

Broxmeyer continued, “Engdahl had done his homework. When questioned regarding the electron pictograph of H1N1 that the CDC recently came up with on their website, he revealed his source, German virologist Dr Stefan Lanka, an expert on the documentation of viruses, attesting to the fact that the H1N1 picture was bogus. The virologist wrote that he had “written the CDC many times as to who made the H1N1 photo’s and whether they where scientifically documented as to chemical characteristics and other properties.” There was never any reply. He concluded “If CDC refuses to cite the source of the photos,  they are fake.” Worse yet he said “The photos are merely liposomes, microscopic artificial sacs whose walls are a double layer of phospholipids, used to carry substances such as drugs, vaccines, and enzymes to specific cells or organs of the body. These have been artificially presented by a process where chick embryos or cell cultures are killed, reduced and then centrifuged with some solvent, to then, in a vacuum, be nanofiltered.” As if this wasn’t enough, the virologist testified that “Such a structure has never been characterized in either an organism or its fluids. Furthermore, if there wasn’t for the centrifuge/solvent/nanofiltration manipulation, not to mention the precipitation procedure, such particles could never be presented under the electron microscope. In conclusion, without the isolation of the H1N1, there is no H1N1 infecting virus”

Engdahl wasn’t finished. “Even more bizarre is the admission by the US Government’s Food and Drug Administration, an agency responsible for the health and safety of its citizens, that the ‘test’ approved for premature release to test for H1N1 is not even a proven test. More to the point”, continues F. William Engdahl, “there is no forensic evidence in any of the deaths reported to date that has been presented that proves scientifically that any single death being attributed to H1N1 Swine Flu virus was indeed caused by such a virus.”

The case for TB

Broxmeyer, who has researched the problem for years is convinced what is appearing is what appear as “virus-like particles.” He states, “’Virus-like particles’ do not mean virus. Viral-like, cell-wall-deficient forms of tuberculosis, for example, also appear virus-like and apparently so also did non-infectious liposomes.”

Both the World Health Organization (WHO) and the Centers for Disease Control (CDC) are fully aware of a far more serious and ongoing tuberculosis Pandemic in the world today. Yet they choose to downplay the link, disregarding the similar flu-like symptoms tuberculosis often begins with.

WHO freely admits that there were approximately 1.8 million deaths from tuberculosis in 2007, the most recent year for which data are available as well as that presently about one-third of the world’s population, or two billion people, carry the TB bacteria.

But in the USA the Government’s Center for Disease Control and Prevention (CDC) ignores everything but “The Virus”. Significantly, deaths from TB and viral pneumonia were recently lumped together with deaths from influenza by the WHO, meaning WHO can falsely claim all TB deaths as “H1N1 Influenza and related” deaths and apparently does so. The extent of political manipulation and deception in the WHO in recent years rivals that of the CIA for deviousness by all indications.

Broxmeyer also recalls that there was much the same “Influenza” talk in 1990, when a new multi-drug-resistant (MDR) tuberculosis outbreak took place in a large Miami municipal hospital. Soon thereafter, similar outbreaks in three New York City hospitals left many sufferers dying within weeks. By 1992, approximately two years later, drug-resistant tuberculosis had spread to deadly mini-epidemics in seventeen US states, and was reported, not by the American, but the international media, as out of control. Viral forms of swine, avian and human TB can be transmitted from one species to another. By 1993 the World Health Organization (WHO), proclaimed tuberculosis a global health emergency.”3

1918 and now

One of the most terrifying images that has been used by spokesmen for WHO, by the pharma industry and various beneficiaries of the current “swine flu” panic is that of the 1918 “Spanish Flu” which is said to have resulted in more deaths than all World War I. Was it really a flu? Broxmeyer is convinced as others that it wasn’t. A Press Release, issued on August 19, 2008, by the National Institute of Allergy and Infectious Diseases (NIAID), contains a striking finding and conclusion: The 20 to 40 million deaths worldwide from the great 1918 Influenza (”Flu”) Pandemic were NOT due to “flu” or a virus, but to pneumonia caused by massive bacterial infection.”4

A study published in the US Journal of the American Medical Association (JAMA) in 2000 showed that Mexican immigrants to the US have the highest case rates for tuberculosis among foreign born persons. Mexico is the country where Swine Flu deaths were first documented.

Lawrence Broxmeyer believes that the 1918 pandemic was due to bacteria, particularly mutant forms of flu-like fowl, swine, bovine, and human tuberculosis (TB) bacteria. “These forms of tuberculosis are often viral-like, mutate frequently and can “skip” from one species to another. Moreover the antibodies from such viral TB forms react in the compliment fixation and later “viral” assays. They also grow on cultures which are supposed to grow only viruses,” he notes.

University of California demographers Andrew Noymer and Michael Garenne came up with convincing statistics showing that undetected tuberculosis may have been the real killer in the 1918 flu epidemic.

Dr. Robert Donaldson, of the Pathological Society of Great Britain has concluded that there wasn’t “the slightest shred of evidence” that the 1918 disease was due to a “virus” or influenza.

As Professor Hans Rosling has pointed out, during the initial 13 days that WHO started gaining data on Swine Flu Deaths, April 24-May 06, 2009, 31 people died of Swine Flu. 29 of these were in Mexico and 2 in the US. During this same 13 days, 63,000 people, around the world died of tuberculosis. What we have today, is a pandemic with “flu-like” symptoms. And flu-like symptoms doesn’t mean “Influenza” is its underlying cause.


1 Vinay Kumar, et al, (2007). Robbins Basic Pathology (8th ed.). Saunders Elsevier. pp. 516–522.

2 Greg Miskiw, MILLION HIT BY 'PLAGUE WORSE THAN SWINE FLU', London Daily Express, November 15, 2009.

3 F Talay, et al, Factors associated with Treatment Success for Tuberculosis Patients: a Single Center's Experience in Turkey , Japan. Journal of Infectious Diseases, vol. 61,pp. 25-30, 2008.

4 D.M. Morens et al. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: Implications for pandemic influenza preparedness. The Journal of Infectious Diseases DOI: 10.1086/591708 (2008).

The Senate’s Christmas Gift

Not so "merry christmas." If the Healthcare bill passes, the massive tax increases go into effect immediately after Obama signs the bill...and with it, booming unemployment as small businesses can't stay afloat. The real kicker? The healthcare benefits don’t start until 2014. All the taxes are designed to confiscate the wealth of Mr. and Mrs. Citizen and drive them into a public option—even as Senate Democrats say the bill doesn’t include one, yet. On Dec. 16 the president went on television and said if Congress doesn’t pass a healthcare bill the Federal government will go bankrupt. Poppycock. If a healthcare bill is passed it’s Mr. and Mrs. Citizen that go belly up.

 

December 21, 2009 by Bob Livingston

The Senate’s Christmas Gift

Senate Democrats are working overtime to get an Obamacare bill passed before Christmas. They no longer even pretend to be doing it to reform healthcare. Now they’re just doing whatever it takes to get a bill passed, even if it costs somewhere between $848 billion and $2.1 trillion, depending on which math you use.

Never mind that the Realclearpolitics.com average of polls shows that Americans oppose the Democrat’s healthcare bill by a 54.2 percent to 39.7 percent margin. Democrats have gone all in, as the saying goes, and nothing is going to stop them.

As an unnamed Democratic strategist told Byron York of The Washington Examiner, “Once you’ve gone this far, what is the cost of failure?”

Comparing Democrats to bank robbers—how appropriate—who have gone past the point of no return, the strategist said, “They’re in the bank, they’ve got their guns out. They can run outside with no money, or they can stick it out, go through the gunfight, and get away with the money.”

Of course, money is what it’s all about. Not saving it mind you, but stealing yours.

Sen. Dick Durbin (D.-Ill.) told The Hill that Democrats will have the 60 votes needed to pass a bill this week. They’re buying off reluctant Democrats left and right.

For Louisiana Sen. Mary Landrieu the price was $300 million in federal aid to her state. As columnist Charles Krauthammer said on Fox News, if Landrieu got $300 million, Sen. Ben Nelson (D.-Neb.)—said to be holding out for removal of a provision in the bill that allows federal funding to pay for abortions—gets a Caribbean island, or two. Or, if some news reports are correct, a threat to close a military base in his state if he doesn’t join in.

Sen. Joe Lieberman (I.-Conn.) is back on board. We don’t yet know what he got in return, aside from a lot of face time on television. In an effort to get one or more Republicans to sign on so the bill can be cast as bi-partisan, Maine Republican Senators Susan Collins and Olympia Snowe are being courted as well. Look for Maine to get a bundle of cash for snow plows or something.

Meanwhile, Joe and Jane Citizen only get dunned. If you are a family with an annual income above $88,200 and your employer doesn’t provide coverage, prepare to fork out $15,200 a year for a federally-mandated insurance fee, according to the Congressional Budget Office (CBO) as reported by CNSNews.com. And few employers are going to provide coverage for their employees once the plan kicks in.

Why? There is an incentive not to. If employers don’t pay their share of their employees’ premiums they’ll have to pay $750 per employee fine. That’s much less than the employer contribution on a complete health plan.

What’s more, there are tax increases in the bill. Lots of them. According to the Heritage Foundation, Medicare taxes increase from 2.9 percent to 3.4 percent, the top marginal tax rate goes from 35 percent to 39.6 percent and, in the House version of the bill, a surtax of 5.4 percent is put on incomes above $500,000.

Following is a list from the Heritage Foundation of other tax increases currently in either the House or Senate bill or proposed by the Barack Obama administration to “pay” for healthcare reform:

  • An excise tax on high-cost "Cadillac" health insurance plans that cost more than $8,500 a year for individuals or $23,000 for families.
  • An excise tax on medical devices such as wheelchairs, breast pumps and syringes used by diabetics for insulin injections.
  • A cap on the exclusion of employer-provided health insurance without offsetting tax cuts.
  • A limit on itemized deductions for taxpayers with a top income tax rate greater than 28 percent.
  • A windfall profits tax on health insurance companies.
  • A value-added tax, which would tax the value added to a product at each stage of production.
  • An excise tax on sugar-sweetened beverages including non-diet soda and sports drinks.
  • Higher taxes on alcoholic beverages including beer, wine and spirits.
  • A limit on contributions to health savings accounts.
  • An 8 percent tax on all wages paid by employers that do not provide their employees health insurance that satisfies the requirements defined by the Secretary of Health and Human Services.
  • A limit on contributions to flexible spending arrangements.
  • Elimination of the deduction for expenses associated with Medicare Part D subsidies.
  • An increase in taxes on international businesses.
  • Elimination of the tax credits paper companies take for biofuels they create in their production process—the so-called “Black Liquor credit.”
  • Fees on insured and self-insured health plans.
  • A limit or repeal of the itemized deduction for medical expenses.
  • A limit on the Qualified Medical Expense definition.
  • An increase in the payroll taxes on students.
  • An extension of the Medicare payroll tax to all state and local government employees.
  • An increase in taxes on hospitals.
  • An increase in the estate tax.
  • Increased efforts to close the mythical “tax gap.”
  • A 5 percent tax on cosmetic surgery and similar procedures such as Botox treatments, tummy tucks and face lifts.
  • A tax on drug companies.
  • An increase in the corporate tax on providers of health insurance.
  • A $500,000 deduction limitation for the compensation paid by health insurance companies to their officers, employees and directors.

And the kicker is the taxes go into effect immediately after Obama signs the bill. The healthcare benefits don’t start until 2014.

All the taxes are designed to confiscate the wealth of Mr. and Mrs. Citizen and drive them into a public option—even as Senate Democrats say the bill doesn’t include one, yet.

On Dec. 16 the president went on television and said if Congress doesn’t pass a healthcare bill the Federal government will go bankrupt. Poppycock. If a healthcare bill is passed it’s Mr. and Mrs. Citizen that go belly up.

The spend-and-tax policies of Obama and the Democrats—stimulus bills, TARP bill, healthcare bill, etc.—are what is pushing us toward economic collapse.

Face it. The healthcare reform plan Democrats are ramming through is nothing more than the greatest transfer of wealth and most massive power grab in the history of the world.

Frankly, I don’t consider that much of a Christmas present.

Sunday, December 13, 2009

Figures Indicate Declines In Net Worth And A Difficult Path To Recovery

Bob Chapman, The International Forecaster

real property value losses and a recovery hindered by more foreclosures and higher interest rates, employment to remain flat, figures indicate record losses, continued worries for the economy,

Congressional appropriators agreed Tuesday night to give civilian federal employees a 2 percent pay increase -- which includes a locality pay increase President Obama didn't want.

Government workers will get a 1.5 percent nationwide increase in base pay and a 0.5 percent average increase in locality pay. The final agreement goes against the wishes of Obama, who called for a flat 2 percent jump and no locality increase.

Locality pay helps address the gaps between federal pay and private sector wages in high-cost areas of the country. The Federal Salary Council estimates the current private-public gap is about 26 percent, on average. Locality increases mean a federal worker in Cincinnati might get a smaller increase than a worker in Washington, D.C., because of local costs of living. [Why aren’t Social Security recipients and disabled veterans receiving their COLA raises for the next few years as well?]

US homeowners have lost about $5.9 trillion in value since the housing market’s peak in March 2006 as mounting foreclosures and the recession weighed on prices, according to Zillow.com.

Almost half a trillion dollars was wiped out this year through November as housing headed for a third straight annual decline. New foreclosures and higher mortgage rates in 2010 may hinder a rebound, the property data service said yesterday.

“A phenomenal amount of wealth has been erased since the housing bust,’’ Stan Humphries, the chief economist for Seattle-based Zillow, said Tuesday in an interview. “For many households, most of their wealth is tied up in real estate.’’

The net worth of US households at the end of June fell 19 percent from two years earlier to $53.1 trillion, according to Federal Reserve data. Employers have cut more than 7.2 million jobs since the start of the recession in December 2007.

The slowing of property declines because of a government tax credit for first-time buyers and record-low mortgage rates will be tested as more foreclosures reach the market and borrowing costs rise, Humphries said. More than two-thirds of the 154 markets tracked by Zillow have lost value this year.

The value of US housing today is about $24.7 trillion, down 19 percent from the market’s peak, according to Zillow.

Wells Fargo & Co., the bank that gained a portfolio of option adjustable-rate mortgages when it bought Wachovia Corp. last year, cut the principal for delinquent borrowers in some loans by as much as 30 percent.

Wells Fargo has forgiven an average of $46,000 in principal, or 15 percent, for the 43,500 option-ARM loans it has modified this year through September, said Franklin Codel, chief financial officer at the bank’s home-lending unit. The San Francisco-based lender has cut as much as 30 percent off the loan principal in a few “rare exceptions,” with the ceiling typically capped at 20 percent, Codel said.

“Right away we decided we wanted to go after the highest- risk borrowers,” Codel said in an interview yesterday from Des Moines, Iowa, where Wells Fargo Home Mortgage is based. “Principal forgiveness is one of the arrows in the quiver.”

In the second-quarter, 15.2 percent of option-ARMs were seriously delinquent, almost triple the 5.3 percent rate for all home loans, according to joint figures from the Office of the Comptroller of the Currency and the Office of Thrift Supervision. As U.S. home prices declined, the Federal Deposit Insurance Corp. and the Center for Responsible Lending have called for banks to reduce the principal for borrowers who owe more than their property is worth.

Wells Fargo has modified about $15.7 billion of option-ARMs in the first three quarters, Codel said. It wrote down $2 billion in loan balances, leaving $13.7 billion in modified mortgages that no longer qualify as option-ARMs, according to a third-quarter presentation.

The U.S. Freight Transportation Index fell in October to its lowest level for October since 1996, as industry shipments decreased for two months in a row.

Shipments suffered their biggest October year-on-year decline, falling 10.5 percent, since the department began calculating the index 20 years ago.

The Freight TSI measures the month-to-month changes in freight shipments in ton-miles, which are then combined into one index.

The index measures the output of the for-hire freight transportation industry and consists of data from for-hire trucking, rail, inland waterways, pipelines and air freight.

FROM A SHOPPER: This happened at Wal-Mart (Supercenter Store #1279, 10411 N Freeway 45, Houston, TX 77037) a month ago. I bought a bunch of stuff, over $150 worth, and I glanced at my receipt as the cashier was handing me the bags. I saw a cash-back of $40. I told her I didn't request cash-back, and to delete it. She said I'd have to take the $40, because she couldn't delete it.

I told her to call a supervisor. The supervisor came, and said I'd have to take it. I said NO! Taking the $40 would be a cash advance against my Discover card, and I wasn't going to pay interest on a cash advance!!!!! If they couldn't delete it, then they would have to delete my whole order. So the supervisor had the cashier delete the whole order and re-scan everything. This second time around I looked at the electronic pad before I signed, and an unwanted cash-back of $20 popped up. At that point I told the cashier, and she deleted it. The total came out right.

The cashier agreed that the electronic pad must be defective. However, it was obvious that the cashier already knew that the electronic pad was defective because the first time around, although the $40 cash back showed up on the receipt, she kept quiet and NEVER offered me the money, like she should have! She intended to pocket my $40.

Can you imagine how many people went through before me, and at the end of her shift how much money she pocketed?

Few employers plan to ramp up hiring early next year, two surveys show – evidence that the economic recovery isn't likely to create many jobs anytime soon.

That will mean fierce competition for job openings that do exist. Nearly 6.3 unemployed workers, on average, are vying for each opening, government figures released Tuesday show. When the recession began, only 1.7 jobless workers were competing for each opening.

More of America's largest companies will shrink their staffs than will hire in the next six months, according to a quarterly survey from the Business Roundtable, a group of large-company CEOs released Tuesday.

Nineteen percent of the CEOs expect to expand their work forces, while 31 percent predict a decrease in the next six months, the survey found. That's slightly better than the 13 percent who expected to increase hiring three months earlier. At that time, 40 percent forecast cuts.

More chief executives foresee higher sales and capital spending compared with three months ago. But "it still will take some time for these gains to translate into more jobs," said Ivan Seidenberg, CEO of Verizon Communications and chairman of the Roundtable.

Separately, a survey of 28,000 employers by staffing company Manpower Inc. found that hiring may improve in the first quarter of 2010 compared with the current quarter – but any gains will likely be slight.

Manpower said its hiring index rose to 6. It was the first positive reading since the first quarter of 2009. Still, that's far below the 18 the index reached in the fourth quarter of 2007, when the recession began.

Economists say employment at large firms is likely to remain flat through much of 2010. Many companies already have hit their hiring targets for what's expected to be a weak and bumpy recovery.

The number of U.S. workers filing new claims for jobless benefits rose more than economists expected last week, the Labor Department said in its weekly report Thursday.

Total claims lasting more than one week, meanwhile, fell.

Initial claims for jobless benefits rose by 17,000 to 474,000 in the week ended Dec. 5. The previous week's level was unrevised at 457,000.

Economists surveyed by Dow Jones Newswires expected an increase of 8,000 initial claims.

An economist at the Labor Department said Thursday that an increase in claims is generally expected during this time of year because it reflects data from the week after Thanksgiving and because construction lay-offs tend to occur in that week.

"Generally...that week sees the biggest percentage increase in initial claims over the year, and this year was no exception," he said.

Although initial claims rose last week, the four-week moving average, which aims to smooth volatility in the data, still continued to drop. The Labor Department said the four-week moving average fell by 7,750 to 473,750 from the previous week's revised average of 481,500. That is the lowest figure since September 27, 2008.

Michelle Meyer, an economist at Barclays Capital, said in an interview Wednesday that despite the predicted increase in claims, she also expected the four-week moving average to continue to decline in a positive sign for the labor market.

"You are still seeing an improving trend," she said. "You are still experiencing an overall downturn in jobless claims."

In the Labor Department's Thursday report, the number of continuing claims--those drawn by workers for more than one week in the week ended Nov. 28 --fell by 303,000 to 5,157,000 from the preceding week's revised level of 5,460,000.

The unemployment rate for workers with unemployment insurance for the week ended Nov. 28 decreased to 3.9%, a 0.2 percentage point decline from the prior week's unrevised rate of 4.1%.

The largest increase in initial claims for the week ended Nov. 28 was in Wisconsin due to layoffs in the construction, service and manufacturing sectors. The largest decrease in initial claims occurred in California.

T he U.S. trade deficit narrowed unexpectedly in October, falling to $32.94 billion, as the rise in exports from September of goods such as cars was slightly higher than the increase in imports.

The figure, representing the U.S. deficit in international trade of goods and services, is 7.6% lower than the downwardly revised $35.65 billion trade gap the U.S. ran in September, the Commerce Department reported Thursday.

Economists surveyed by Dow Jones Newswires had expected the October trade deficit would widen to $37.0 billion. The September trade gap was originally estimated to be $36.5 billion.

The real, or inflation-adjusted deficit, used by economists to measure the impact of trade on gross domestic product, fell to $38.0 billion in October from a downwardly revised $41.49 billion in September.

U.S. GDP, a broad range of economic activity, rose in the third quarter by an annualized 2.8%, the first increase in more than a year. However, the economy's expansion was limited by a wider trade deficit, with net exports subtracting 0.8 of a percentage point to GDP in the July-September period.

Thursday's report showed U.S. exports in October rose 2.6% to $136.84 billion, the highest level in nearly a year, from $133.38 billion the previous month.

Imports rose by just 0.4% to $169.78 billion from $169.03 billion in September, but that was still the highest level in U.S. imports since Dec. 2008.

The U.S. paid $17.44 billion for crude oil imports in October, down from $19.51 billion the month before. After rising for seven months in a row, the average price per barrel was the lowest since January 2000, falling to $67.39 from $68.17 in September. Crude import volumes fell to 258.83 million barrels from 286.22 million barrels.

The total U.S. bill for all types of energy-related imports fell to $22.45 billion in October from $24.87 billion in September.

Imports of foreign-made consumer goods rose $1.0 billion in October, with imports of auto and related parts rising by $0.4 billion from September. Purchases of capital goods increased by $1.1 billion.

U.S. exports of consumer goods, including artwork and jewelry, rose by $1.0 billion in October compared to the prior month. The value of U.S. exports of industrial supplies, such as steelmaking material and gold, increased by $0.4 billion. Auto and related products exports also rose by $0.4 billion from September.

Meanwhile, capital goods exports rose by $1.2 billion in October from the previous month.

The U.S. trade gap with China was the highest since Nov. 2008, rising to $22.7 billion in October from the previous month's $22.1 billion. The trade deficit with Japan rose to $4.4 billion from $4.1 billion in September.

However, the U.S. trade deficit with some other major trading partners narrowed slightly. The deficit with the European Union fell to $4.9 billion from $5.5 billion a month earlier, while the trade shortfall with Mexico was unchanged at $4.6 billion.

Foreclosure filings in the U.S. will reach a record for the second consecutive year with 3.9 million notices sent to homeowners in default, RealtyTrac Inc. said.

This year’s filings will surpass 2008’s total of 3.2 million as record unemployment and price erosion batter the housing market, the Irvine, California-based company said.

“We are a long way from a recovery,” John Quigley, economics professor at the University of California, Berkeley, said in an interview. “You can’t start to see improvement in the housing market until after unemployment peaks.”

Foreclosure filings exceeded 300,000 for the ninth straight month in November, RealtyTrac said today. A weak labor market and tight credit are “formidable headwinds” for the economy, Federal Reserve Chairman Ben S. Bernanke said in a Dec. 7 speech in Washington. The 7.2 million jobs lost since the recession began in December 2007 are the most of any postwar economic slump, Labor Department data show. Unemployment, at 10 percent last month, won’t peak until the first quarter, Quigley said.

Loan-modification programs and an expanded government tax credit for first-time homebuyers are helping slow the monthly pace of filings and “keeping a lid” on further foreclosures, James Saccacio, RealtyTrac’s chief executive officer, said in the statement.

Pregnant woman gets brain damage from "swine flu" shot

A 37-year old woman in Gothenburg Sweden had a perfecr pregnancy without any complications.. Eight weeks before the expected birth, she had the poisonous Pandemrix "swine flu" shot and after a few days she fell ill with influenza like symptoms.
Her husband shares how he found her on the floor early one morning: "- She was up around four o'clock in the morning and I heard how she fell to the floor in the living room. I ran there and pulled her onto the sofa and tried to communicate with her but all she did was throwing up."
At the hospital, doctors found she suffered from massive hemorrhage to the brain and decided to immediately take the baby out.
For three weeks, her man has been living in total chaos, rushing between the two different hospitals - one where his son is treated for the early birth and the other where his woman is treated for the massive hemorrhage to her brain.
And again: "It is too early to say if this had anything to do with the vaccination. We will have to analyze the report and investigate." says professor Jan Liliemark at the Swedish Medical Products Agency.

Original article

WHO 'Mr Flu' under investigation for gross conflict of interest

F. William Engdahl

Financial Sense
December 8, 2009

The man with the nickname "Dr Flu", Professor Albert Osterhaus, of the Erasmus University in Rotterdam Holland has been named by Dutch media researchers as the person at the center of the worldwide Swine Flu H1N1 Influenza A 2009 pandemic hysteria. Not only is Osterhaus the connecting person in an international network that has been described as the Pharma Mafia, he is THE key advisor to WHO on influenza and is intimately positioned to personally profit from the billions of euros in vaccines allegedly aimed at H1N1.

Earlier this year the Second Chamber of the Netherland Parliament undertook an investigation into alleged conflicts of interest and financial improprieties of the well-known Dr. Osterhaus. Outside Holland and a mention at the time in the Dutch media, the only note of the sensational investigation into Osterhaus’ business affairs came in a tiny note in the respected British magazine, Science.

Osterhaus's credentials and expertise in his field were not in question. What is according to a short report published by the journal Science, are his links to corporate interests that stand to potentially profit from the swine flu pandemic. Science carried the following brief note in its October 16 2009 issue about Osterhaus:

"

For the past 6 months, one could barely switch on the television in the Netherlands without seeing the face of famed virus hunter Albert Osterhaus talking about the swine flu pandemic. Or so it has seemed. Osterhaus, who runs an internationally renowned virus lab at Erasmus Medical Center, has been Mr. Flu. But last week, his reputation took a nosedive after it was alleged that he has been stoking pandemic fears to promote his own business interests in vaccine development. As Science went to press, the Dutch House of Representatives had even slated an emergency debate about the matter."

On November 3, 2009 it appeared that Osterhaus emerged with at least the damage somewhat under control. An updated Science blog noted, "The House of Representatives of the Netherlands today rejected a motion asking the government to sever all ties with virologist Albert Osterhaus of Erasmus Medical Center in Rotterdam, who had been accused of conflicts of interest in his role as a government adviser. But Dutch health minister Ab Klink, meanwhile, announced a "Sunshine Act" compelling scientists to disclose their financial ties to companies."

The Minister, Ab Klink, reportedly a personal friend of Osterhaus, subsequently issued a statement on the ministry’s website, claiming that Osterhaus was but one of many scientific advisers to the ministry on vaccines for H1N1, and that the Ministry "knew" about the financial interests of Osterhaus. Nothing out of the ordinary, merely pursuit of science and public health so it seemed.

More careful investigation into the Osterhaus Affair suggests that the world-renowned Dutch Virologist may be at the very center of a multi-billion Euro pandemic fraud which has used human beings in effect as human guinea pigs with untested vaccines and in cases now emerging resulting in deaths or severe bodily paralysis or injury.

The ‘Bird Shit Hoax’

Albert Osterhaus is no small fish. He stands at the global nexus of every major virus panic of the past two decades from the mysterious SARS deaths in HongKong, where current WHO Director Margaret Chan got her start in her career as a local health official. According to his official bio at the European Commission, Osterhaus was engaged in April 2003, at the height of the panic over SARS (Severe Acquired Respiratory Syndrome) in Hong Kong. The EU report states, "he again showed his skill at moving fast to tackle a serious problem. Within three weeks he had proved that the disease was caused by a newly discovered coronavirus that resides in civet cats, other carnivorous animals or bats."

Then Osterhaus moved on, this time publicizing dangers of what he claimed was H5N1 Avian Flu. In 1997 he already began sounding the alarm following the death in Hong Kong of a three-year-old who Osterhaus learned had had direct contact with birds. Osterhaus went into high gear lobbying across Holland and Europe claiming that a deadly new mutation of avian flu had jumped to humans and that drastic measures were required. He claimed to be the first scientist in the world to show that H5N1 could be transferred into humans.

In a BBC interview in October 2005 on the danger of Avian Flu, Osterhaus declared, "…if the virus manages indeed to, to mutate itself in such a way that it can transmit from human to human, then we have a completely different situation, we might be at the start of the pandemic." He added, "there is a real chance that this virus could be trafficked by the birds all the way to Europe. There is a real risk, but nobody can estimate the risk at this moment, because we haven't done the experiments." It never did manage to mutate, but he was ready to "do the experiments," presumably for a hefty fee.

To bolster his frightening pandemic scenario, Osterhaus and his lab assistants in Rotterdam began assiduously assembling and freezing samples of, well, bird shit, in an attempt to build a more scientific argument. He claimed that at certain times of the year up to 30% of all European birds acted as carriers of the deadly avian virus, H5N1. He also claimed that farmers working with hens and chickens were then exposed. Osterhaus briefed journalists who dutifully noted his alarm. Politicians were alerted. He wrote papers proposing that the far away deaths in Asia from what he termed H5N1 were coming to Europe. He claimed that migratory birds were carrying the deadly new disease as far west as Rügen and Ukraine.

Osterhaus’ Avian Flu alarm campaign really took off in 2003 when a Dutch veterinary doctor became ill and died. Osterhaus claimed the death was from H5N1. He convinced the Dutch government to order slaughter of millions of chickens. Yet no other infected persons died from the alleged H5N1. Osterhaus claimed that that was simply proof of the effectiveness of the preemptive slaughter campaign.

Osterhaus claimed that bird feces were the source, via air bombardment or droppings, onto populations and birds below, of the spread of the deadly new Asian strain of H5N1. There was only one problem with the now voluminous frozen samples of diverse bird excrement he and his associated had collected and frozen at his institute. There was not one single confirmed example of H5N1 virus found in any of his samples.

At a May 2006 Congress of the World Organization for Animal Health (OIE), Osterhaus and his Erasmus colleagues were forced to admit that in testing 100,000 samples of their assiduously saved bird feces, they had discovered not one single case of H5N1 virus.

At a WHO conference in Verona in 2008 titled "Avian influenza at the Human-Animal Interface," in a presentation to scientific colleagues undoubtedly less impressed by appeals to pandemic emotion than the non-scientific public, Osterhaus admitted that "A proper risk assessment of H5N1 as the cause of a new pandemic cannot be made with the currently available information." By then, however, his sights were already firmly on other possible pandemic triggers to focus his vaccination activities.

Swine Flu and WHO corruption

When no mass wave of human deaths from Avian Flu materialized and after Roche, maker of Tamiflu and GlaxoSmithKline had banked billions of dollars in profits from worldwide government stockpiling of their dangerous and reportedly ineffective antiviral drugs, Tamiflu by Roche, and Relenza by GlaxoSmithKline, Osterhaus and other WHO advisers turned to other greener pastures.

By April 2009 their search seemed rewarded as a small Mexican village in Veracruz reported a case of a small child ill with what had been diagnosed as "Swine Flu" or H1N1. With indecent haste the propaganda apparatus of the World Health Organization in Geneva went into gear anth statements from the director-general Dr Margaret Chan, about a possible danger of a global pandemic. Chan made such irresponsible statements as declaring "a public health emergency of international concern."

The further cases of outbreak at La Gloria Mexico were reported on one medical website as, "a ‘strange’ outbreak of acute respiratory infection, which led to bronchial pneumonia in some pediatric cases. According to a local resident, symptoms included fever, severe cough, and large amounts of phlegm."

Notably those were symptoms which would make sense in terms of the proximity of one of the world’s largest pig industrial feeding concentrations at La Gloria owned by Smithfield Farms of the USA. Residents had picketed the Smithfield Farms site in Mexico for months complaining of severe respiratory problems from the fecal waste lagoons. That possible cause of the diseases in La Gloria apparently did not interest Osterhaus and his colleagues advising the WHO. The long-awaited "pandemic" that Osterhaus had predicted ever since his involvement with SARS in the Guandgong Province of China in 2003, was now finally at hand.

On June 11, 2009 Margaret Chan of WHO made the declaration of a Phase 6 "Pandemic Emergency" regarding the spread of H1N1 Influenza. Curiously in announcing she noted, "On present evidence, the overwhelming majority of patients experience mild symptoms and make a rapid and full recovery, often in the absence of any form of medical treatment." She then added, "Worldwide, the number of deaths is small…we do not expect to see a sudden and dramatic jump in the number of severe or fatal infections."

It later was learned that Chan acted, following heated debates inside WHO, on the advice of the scientific advisory group of WHO, or SAGE, the Strategic Advisory Group of Experts. One of the members of SAGE at the time and today was Dr. Albert "Mr Flu" Osterhaus. Not only was Osterhaus in a key position to advocate the panic-inducing WHO "Pandemic emergency" declaration. He was also chairman of the leading private European Scientific Working group on Influenza, which describes itself as a "multidisciplinary group of key opinion leaders in influenza [that] aims to combat the impact of epidemic and pandemic influenza." Osterhaus’ ESWI is the vital link as they themselves describe it "between the World Health Organization (WHO) in Geneva, the Robert Koch Institute in Berlin and the University of Connecticut, USA."

What is more significant about the ESWI is that its work is entirely financed by the same pharma mafia companies that make billions on the pandemic emergency as governments around the world are compelled to buy and stockpile vaccines on declaration of a WHO Pandemic. The funders of ESWI include H1N1 vaccine maker Novartis, Tamiflu distributor, Hofmann-La Roche, Baxter Vaccines, MedImmune, GlaxoSmithKline, Sanofi Pasteur and others.

Not to lose the point, the world-leading virologist, official adviser on H1N1 to the governments of the UK and Holland, Dr Albert Osterhaus, head of the Department of Virology at the Erasmus MC of Rotterdam, also sat on the WHO’s elite SAGE and served as chairman at the same time of the pharma industry-sponsored ESWI which urged dramatic steps to vaccinate the world against the grave danger of a new Pandemic they insisted could rival the feared 1918 Spanish Flu pandemic.

The Wall Street bank, JP Morgan estimated that in large part as a result of the WHO pandemic decision, the giant pharma firms that also finance Osterhaus’ ESWI work, stand to reap some €7.5 to €10 billion in profits.

A fellow member of WHO’s SAGE is Dr Frederick Hayden, of Britain’s Wellcome Trust and reportedly a close friend of Osterhaus. Hayden also receives money for "advisory" services from Roche and GlaxoSmithKline among other pharma giants involved in producing products related to the H1N1 panic.

Chairman of WHO’s SAGE is another British scientist, Prof. David Salisbury of the UK Department of Health. He also heads the WHO H1N1 Advisory Group. Salisbury is a robust defender of the pharma industry. He has been accused by UK health citizen health group One Click of covering up the proven links between vaccines and an explosive rise in infant autism as well as links between Gardasil and palsy and even death.

Then on September 28, 2009 the same Salisbury stated, "Professor David Salisbury, the department of health’s director of immunisation, said: "There is a very clear view in the scientific community that there is no risk from the inclusion of Thiomersal." The vaccine being used for H1N1 in Britain is primarily produced by GlaxoSmithKlilne and contains the mercury preservative Thiomersol. Because of growing evidence that Thiomersol in vaccines might be related to autism in children in the United States, in 1999 the American Academy of Pediatrics and the US Public Health Service called for it to be removed from vaccines.

Yet another SAGE member at WHO with intimate financial ties to the vaccine makers that benefit from SAGE’s recommendations to WHO is Dr. Arnold Monto, a paid consultant to vaccine maker MedImmune, Glaxo and ViroPharma.

Even more the meetings of the "independent" scientists of SAGE are attended by "observers" who include, yes, the very vaccine producers GlaxoSmithKline, Novartis, Baxter and company. In the past decade the WHO, in order to boost funds at its disposal entered into what it calls "public private partnerships." Instead of receiving its funds solely from member United Nations governments as its original purpose had been, WHO today receives almost double its normal UN budget in the form of grants and financial support from private industry. The industry? The very drug and vaccine makers who benefit from decisions like the June 2009 H1N1 Pandemic emergency declaration. As the main financiers of the WHO bureaucracy, naturally the Pharma Mafia and their friends receive what has been called "open door red carpet treatment" in Geneva.

In an interview with Der Spiegel magazine in Germany, epidemiologist Dr. Tom Jefferson of the Cochrane Collaboration, an organization of independent scientists evaluating all flu related studies, noted the implications of the privatization of WHO and the commercialization of health:

"…one of the extraordinary features of this influenza -- and the whole influenza saga -- is that there are some people who make predictions year after year, and they get worse and worse. None of them so far have come about, and these people are still there making these predictions. For example, what happened with the bird flu, which was supposed to kill us all? Nothing. But that doesn't stop these people from always making their predictions. Sometimes you get the feeling that there is a whole industry almost waiting for a pandemic to occur.

SPIEGEL: Who do you mean? The World Health Organization (WHO)?

Jefferson: The WHO and public health officials, virologists and the pharmaceutical companies. They've built this machine around the impending pandemic. And there's a lot of money involved, and influence, and careers, and entire institutions! And all it took was one of these influenza viruses to mutate to start the machine grinding...
When asked if the WHO had deliberately declared the Pandemic Emergency in order to create a huge market for H1N1 vaccines and drugs, Jefferson replied,

"Don't you think there's something noteworthy about the fact that the WHO has changed its definition of pandemic? The old definition was a new virus, which went around quickly, for which you didn't have immunity, and which created a high morbidity and mortality rate. Now the last two have been dropped, and that's how swine flu has been categorized as a pandemic."

Conveniently enough, the WHO published the new Pandemic definition in April 2009 just in time to allow WHO, on advice of SAGE and others like Albert "Dr Flu" Osterhaus and David Salisbury, to declare the mild cases of flu dubbed H1N1 Influenza A to be declared Pandemic.

In a relevant footnote, the Washington Post on December 8 in an article on the severity, or lack of same, of the world H1N1 „pandemic" reported that "with the second wave of H1N1 infections having crested in the United States, leading epidemiologists are predicting that the pandemic could end up ranking as the mildest since modern medicine began documenting influenza outbreaks."

Russian Parliamentarian and chairman of the Duma Health Committee, Igor Barinow has called on the Russian Representative to WHO in Geneva to order an official investigation into the growing evidence of massive corruption of the WHO by the pharmaceutical industry. "There are grave accusations of corruption within the WHO," said Barinow. "An international commission of inquiry is urgently required."

http://www.financialsense.com/editorials/engdahl/2009/1208.html